OVID compared with RZLT: revenue, margins and what each company keeps, and the suppliers and customers both name

OVIDOvid Therapeutics Inc.

Mkt capRevenueRevenue

RZLTRezolute, Inc.

Mkt capRevenueRevenue

Compare

OVIDOvid Therapeutics Inc.

RZLTRezolute, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

OVIDOvid Therapeutics Inc.

2.55▼−0.45%· post 2.54

Mkt cap$496.1MRevenue$733,000Q2 FY26Revenue$7MFY25

RZLTRezolute, Inc.

3.96▼−3.88%· post 3.96

ClosedOct 30 '26

Mkt cap$382.1MRevenue—Revenue—

Compare

ClosedOct 30 '26

OVIDOvid Therapeutics Inc.

RZLTRezolute, Inc.

2.55▼−0.45%post 2.54

Price

3.96▼−3.88%post 3.96

$496.1M

Mkt cap

$382.1M

Q2 FY26$733,000

Revenue

—

FY25$7M

Revenue

—

OVID2.55▼−0.45%vsRZLT3.96▼−3.88%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

OVID, solidRZLT, dashed

Supply-chain overlap

Revenue flow

OVID: latest quarter is a loss; flow not drawable. RZLT: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OVID 7

LGNDLigand Pharmaceuticalscustomer

TAKTakedacustomer

—Northwestern Universityunlistedsupplier

—AstraZenecaunlistedsupplier

3 more · OVID chain ›

Shared 0

No shared counterparties.

Only RZLT 4

XOMAXOMAsupplier

—ActiveSite Pharmaceuticalsunlistedsupplier

—Ligand Pharmaceuticalsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Xoma (u.s.)

unlistedsupplier